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Bone marrow stromal cells (BMSCs) are versatile mesenchymal cell populations underpinning the major functions of the skeleton, a majority of which adjoin sinusoidal blood
vessels and express C-X-C motif chemokine ligand 12 (CXCL12). However, how these cells
are activated during regeneration and facilitate osteogenesis remains largely unknown. Celllineage analysis using Cxcl12-creER mice reveals that quiescent Cxcl12-creER+ perisinusoidal
BMSCs differentiate into cortical bone osteoblasts solely during regeneration. A combined
single cell RNA-seq analysis demonstrate that these cells convert their identity into a skeletal
stem cell-like state in response to injury, associated with upregulation of osteoblast-signature
genes and activation of canonical Wnt signaling components along the single-cell trajectory.
β-catenin deﬁciency in these cells indeed causes insufﬁciency in cortical bone regeneration.
Therefore, quiescent Cxcl12-creER+ BMSCs transform into osteoblast precursor cells in a
manner mediated by canonical Wnt signaling, highlighting a unique mechanism by which
dormant stromal cells are enlisted for skeletal regeneration.

1 University of Michigan School of Dentistry, Ann Arbor, MI 48109, USA. 2 Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI 48109,
USA. 3 Department of Computational Medicine and Bioinformatics, Department of Computer Science and Engineering, University of Michigan, Ann Arbor, MI
48109, USA. 4 Washington University School of Medicine, Division of Oncology, St. Louis, MO 63110, USA. 5 Osaka University School of Medicine,
Laboratory of Stem Cell Biology and Developmental Immunology, Graduate School of Frontier Biosciences, Suita, Osaka 565-0871, Japan.
*email: noriono@umich.edu

NATURE COMMUNICATIONS | (2020)11:332 | https://doi.org/10.1038/s41467-019-14029-w | www.nature.com/naturecommunications

1

ARTICLE

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-14029-w

B

one is a highly regenerative organ that maintains its
structural integrity and functionality throughout life. Bone
marrow stromal cells (BMSCs) are mesenchymal cell
populations with versatile functions that provide the support for
hematopoietic cells and the source of osteoblasts, underpinning
the major functions of the skeleton1. A majority of BMSCs
assume perivascular locations surrounding sinusoids with a reticular morphology2 and universally express cytokines such as
C–X–C motif chemokine 12 (CXCL12, also known as stromal
cell-derived factor 1, SDF1)3,4 and stem cell factor (SCF, also
known as KIT ligand)5. Leptin receptor (LepR) is expressed by a
wide array of BMSCs that largely overlap with CXCL12-abundant
reticular (CAR) cells6. These LepR+CXCL12+ BMSCs cells
populate the osteoblast compartment in adult mice7–9, containing
a self-renewing population particularly those termed as skeletal
stem cells (SSCs) deﬁned by in vitro assays10. However, how
speciﬁc subsets of CXCL12+ BMSCs are activated in response to
injury within their native environment and facilitate skeletal
regeneration remains largely unknown. In this study, we sought
to identify the mechanism underlying the remarkable osteogenic
capacity of CXCL12+ BMSCs in vivo under regenerative conditions. To this end, we generated a Cxcl12-creER line and performed in vivo lineage-tracing experiments and functional
analyses. Our data reveal that quiescent Cxcl12-creER+ BMSCs
transform into precursor cells characterized by a SSC-like
state in a manner mediated by canonical Wnt signaling
during injury responses, and functionally contribute to skeletal
regeneration.
Results
Cxcl12-creER marks a quiescent subset of CXCL12+LepR+
BMSCs. To reveal in vivo cell fates of CXCL12+ BMSCs, we
generated a tamoxifen-inducible Cxcl12-creER bacterial artiﬁcial
chromosome (BAC) transgenic line (L289, Fig. 1a). First, we
characterized this Cxcl12-creER line based on a short-chase protocol. Analysis of Cxcl12GFP/+; Cxcl12-creER; R26RtdTomato mice
at postnatal day (P) 28 after a tamoxifen pulse at P21 revealed
that Cxcl12-creER-marked tdTomato+ (hereafter, Cxcl12CEtdTomato+) cells overlapped completely with Cxcl12-GFPhigh
stromal cells throughout the diaphyseal marrow space (Fig. 1b).
These Cxcl12-GFPhighCxcl12CE-tdTomato+ stromal cells
assumed a characteristic morphology as reticular cells adjoining
endomucin (Emcn)+ sinusoidal endothelial cells (Fig. 1c, Supplementary Fig. 1a) and CD31+ arteriolar endothelial cells
(Fig. 1d). In fact, virtually all Cxcl12-GFPhighCxcl12CEtdTomato+ cells attached Emcn+ sinusoids either through dendrites or by cell bodies (Fig. 1e, 95.7 ± 2.1% of Cxcl12GFPhighCxcl12CE-tdTomato+ cells, compared to 84.6 ± 6.1% of
Cxcl12-GFPhightdTomatoneg cells, n = 5). Flow cytometry analysis revealed that Cxcl12CE-tdTomato+ cells represented an
extremely small fraction of whole bone marrow cells (0.014 ±
0.002%). Cxcl12-creER faithfully marked a subset of Cxcl12GFPhigh cells upon tamoxifen injection; 27.9 ± 3.0% of CD45/
Ter119/CD31negCxcl12-GFPhigh cells were tdTomato+, whereas
97.6 ± 1.1% of CD45/Ter119/CD31negCxcl12CE-tdTomato+ cells
were Cxcl12-GFPhigh (n = 5, Fig. 1f, Supplementary Fig. 8a, b).
Cxcl12CE-tdTomato+ cells ubiquitously expressed leptin receptor
(LepR) (Fig. 1g, Supplementary Fig. 8a, b). Notably, Cxcl12CEtdTomato+ cells were preferentially localized in the central
marrow space (Fig. 1h). In fact, Cxcl12CE-tdTomato+ cells
accounted for a majority of Cxcl12-GFPhigh and LepR+ stromal
cells in the central marrow space (tdTomato+: 70.9 ± 15.5% and
70.3 ± 15.2% of total Cxcl12-GFPhigh and LepR+ cells, respectively). By contrast, Cxcl12CE-tdTomato+ cells accounted for only
a small portion of Cxcl12-GFPhigh and LepR+ stromal cells in the
2

metaphyseal marrow space (tdTomato+: 3.6 ± 2.4% and 2.6 ±
1.7% of total Cxcl12-GFPhigh and LepR+ cells, respectively) or in
the endosteal space (tdTomato+: 16.1 ± 6.2% and 12.6 ± 5.9% of
total Cxcl12-GFPhigh and LepR+ cells, respectively, Fig. 1i),
suggesting that Cxcl12CE-tdTomato+ cells represent a speciﬁc
subset of LepR+CXCL12+ stromal cells that are distant from the
bone surface. Moreover, Cxcl12-creER marked a subset of Cxcl12GFPhigh cells that were characterized by the least mitotic activity
and the most abundant expression of CXCL12 but not SCF
(Fig. 1j–m, Supplementary Fig. 8a, b). Cxcl12CE-tdTomato+ cells
were distinct from mature osteoblasts, as they did not express
Col1a1(2.3 kb)-GFP (Fig. 1n, o, Supplementary Fig. 8a, b).
Importantly, this Cxcl12-creER line had minimal promiscuity in
the stromal cell compartment; although tdTomato+ cells were
occasionally present in Cxcl12-creER; R26RtdTomato mice in the
absence of tamoxifen (6/13 mice, 46%, Supplementary Fig. 1b, c),
virtually all of them were in a CD45/Ter119/CD31+ fraction
(90.9 ± 3.3%, Supplementary Figs. 1b, 8a). Therefore, Cxcl12creER can mark a relatively quiescent subset of CXCL12+ perisinusoidal BMSCs in the central marrow space upon tamoxifen
injection.
Single-cell characterization of Cxcl12-creER+ BMSCs. We
further deﬁned the identity of Cxcl12-creER+ stromal cells by a
single cell RNA-seq analysis. To this end, we interrogated the
proﬁle of ﬂuorescently sorted single cells gated on a GFPhigh
fraction (Supplementary Fig. 8c, d) isolated from Cxcl12GFP/+;
Cxcl12-creER; R26RtdTomato bone marrow at P28 after a tamoxifen pulse at P21 (Mouse #1: 2749 cells, Mouse #2: 4577 cells, total
7326 cells). Initial analysis revealed that a substantial fraction of
cells (Mouse #1: 721/2749 cells, 26.2%, Mouse #2: 747/4577 cells,
16.3%) belonged to the clusters without detectable eGFP expression; these eGFPneg clusters included myeloid cells, lymphocytes,
and erythroid cells (Supplementary Fig. 2), highlighting an issue
on hematopoietic cell contamination commonly observed in
recently published bone marrow stromal datasets11–13. eGFP was
exclusively expressed by cells that abundantly expressed Cxcl12
(Supplementary Fig. 2). Cxcl12-GFP+ cells were heterogeneous
and clustered into nine groups, including three clusters of stromal
(Clusters 0–2), two clusters endothelial (Clusters 4 and 8), one
cluster of periosteal (Cluster 3) cells (Fig. 2a, Supplementary
Fig. 2). Other small clusters included cells in cell cycle (Cluster 6)
and enriched for mitochondrial (Cluster 5) and ribosomal
(Cluster 7) genes. The stromal clusters were composed of a
reticular cell group expressing pre-adipocyte markers such as
Adipoq and Lepr (Cluster 0), and a group expressing preosteoblast markers such as Alpl and Postn (Cluster 1) (Fig. 2a,
Supplementary Fig. 2). Cells in Cluster 0 were relatively enriched
for secreted factors such as Cxcl12, Kitl, Fgf7, and Il7, whereas
those in Cluster 1 were relatively enriched for an osteogenic factor
Clec11a14 (Fig. 2b). Importantly, tdTomato was identiﬁed as a
cell-type speciﬁc marker for Cluster 0 (Fig. 2a, b). Thus, a
majority of Cxcl12CE-tdTomato+ cells belongs to a reticular
cluster in which cells abundantly express adipocyte-related genes
and a variety of cytokines.
We next examined ex vivo properties of Cxcl12-creER+
stromal cells by a colony-forming unit ﬁbroblast (CFU-F) assay
(Supplementary Fig. 3a). To achieve this, we plated whole bone
marrow cells isolated from Cxcl12-creER; R26RtdTomato mice at
P28 (tamoxifen pulse at P21) at a clonal density. Cxcl12-creER
marked only a small fraction of CFU-Fs (3.7 ± 0.8%, compared to
99.7 ± 0.6% of total CFU-Fs by ubiquitous Ubc-creER, Fig. 2c, d);
this is in sharp contrast with LepR-cre and Ebf3-creER that can
mark essentially all CFU-Fs7,9. Therefore, Cxcl12-creER can
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speciﬁcally mark a subset of CXCL12+ BMSCs with little colonyforming activities upon tamoxifen injection.
Subsequently, we tested in vitro passageability of individual
tdTomato+ clones (Supplementary Fig. 3a). Cxcl12CEtdTomato+clones could survive for signiﬁcantly higher
passages than UbcCE-tdTomato+ clones did; while 30.8%
(8/26) of Cxcl12CE-tdTomato+ clones could be passaged over
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4 generations, only 8.3% (4/48) of UbcCE-tdTomato+ clones
could be passaged over the same generation (Fig. 2e, Supplementary Fig. 3b). These Cxcl12CE-tdTomato+ clones exhibited
in vitro trilineage differentiation potential (i.e., adipocytes,
osteoblasts, and chondrocytes, 12/12 clones, 100%, Fig. 3f), and
differentiated into osteoblast-like cells depositing mineralized
matrix upon transplantation into immunodeﬁcient mice
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Fig. 1 Cxcl12-creER marks a quiescent subset of CXCL12+LepR+ BMSCs. a Structure of Cxcl12-iCreER-bGHpA bacterial artiﬁcial chromosome (BAC)
transgene. b–o Short-chase analysis of Cxcl12-creER+ cells. b Cxcl12GFP/+; Cxcl12-creER; R26RtdTomato (pulsed at P21) distal femurs with growth plates on
top. Gray: DIC. Scale bar: 500 µm. n = 3 mice. c, d Immunostaining for endomucin (Emcn, c) and CD31 (d). Sn: sinusoids, At: arterioles. Arrows: sinusoidattaching GFPhightdTomato+ cells. Gray: DAPI. Scale bar: 10 µm. n = 5 mice. e Percentage of cells attaching Emcn+ sinusoids among GFPhightdTomatoneg
(green) or GFPhightdTomato+ (red) cells. n = 5 mice. f Flow cytometry analysis of CD45/Ter119/CD31neg bone marrow cells. Blue lines: control cells. n = 5
mice. g Leptin receptor (LepR) expression based on ﬂow cytometry analysis. Blue line: isotype control. n = 3 mice. h LepR staining. Gray: DAPI (Center),
DIC (metaphysis and endosteal zone). Scale bar: 20 µm. i Quantiﬁcation based on histology. Percentage of BMSCs expressing Cxcl12-GFP (green dots),
Cxcl12CE-tdTomato (red dots) and LepR (purple dots). n = 7 ﬁelds from four mice (central marrow and endosteal surface), n = 5 ﬁelds from 4 mice
(metaphysis). j Percentage of CD45/Ter119/CD31neg subpopulations in S/G2/M phase. n = 5 mice. k Intracellular CXCL12 protein levels of CD45/Ter119/
CD31neg subpopulations. MFI: median ﬂuorescence intensity. n = 4 mice. l EdU serial pulse assay of Cxcl12-creER+ cells. Cxcl12-creER; R26RtdTomato mice
were pulsed with tamoxifen at P21, then with EdU every 8 h for 3 days prior to analysis. Percentage of EdU+ cells among GFPhightdTomatoneg (green) or
GFPhightdTomato+ (red) cells. n = 5 mice. m Intracellular SCF protein levels of CD45/Ter119/CD31neg subpopulations. MFI median ﬂuorescence intensity.
n = 5 mice. n, o Col1(2.3 kb)-GFP; Cxcl12-creER; R26RtdTomato. n Left panel: trabecular bone. Right panel: endosteal space. Gray: DIC. Scale bar: 20 µm. n = 4
mice. o Flow cytometry analysis of CD45/Ter119/CD31neg cells harvested from Col1(2.3 kb)-GFP; Cxcl12-creER; R26RtdTomato at P28 (pulsed at P21) bone
marrow. Blue lines: control cells. n = 4 mice. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, two-tailed, Mann–Whitney’s U test (e, l). Two-tailed, oneway ANOVA followed by Tukey’s post hoc test (i–k, m). All data are presented as mean ± s.d. Source data are provided as a Source Data ﬁle.

(Supplementary Fig. 3c). Thus, these small numbers of CFU-Fs
marked by Cxcl12-creER possess robust in vitro selfrenewability and a propensity to become osteoblasts in a nonnative environment.

line). Therefore, quiescent Cxcl12-creER+ perisinusoidal BMSCs
predominantly stay within the marrow space as CXCL12+
stromal cells and do not migrate and differentiate into cortical
bone osteoblasts in homeostasis.

Cell-fate analysis reveals dormancy of Cxcl12-creER+ BMSCs.
We subsequently deﬁned long-term cell fates of quiescent Cxcl12creER+ BMSCs using Cxcl12-creER; R26RtdTomato mice carrying
either Col1(2.3 kb)-GFP or Cxcl12GFP/+ reporters. These mice
were pulsed at P3, P21, and 8 weeks of age (hereafter, Cxcl12CEP3, Cxcl12CE-P21, and Cxcl12CE-8 W cells, respectively).
Cxcl12CE-P3 cells remained spatially restricted only in a far
proximal portion of the femoral marrow space at 1 year of age
(1 y) (Fig. 3a). Similarly, few Cxcl12CE-P21 cells migrated distally
to contribute to newly formed marrow space beneath the growth
plate toward 1 y (Fig. 3b, Supplementary Figs. 4a–g and 8a, b). By
contrast, Cxcl12CE-8 W cells were distributed throughout the
marrow space at 12 W and 1 y (Fig. 3c, Supplementary Fig. 4h),
demonstrating that a tamoxifen pulse at the adult stage could
label cells under the growth plate that were not labeled when
tamoxifen was given at earlier stages (Fig. 3d). Therefore, these
Cxcl12-creER+ BMSCs are dormant and remain in the original
domain of the marrow space in growing bones, without producing new stromal cells in the newly formed domain of the marrow
space in the metaphyseal region resulting from long-bone growth.
These data also indicate that quiescent Cxcl12-creER+ BMSCs
might be produced by other mesenchymal precursor cells during
bone growth, such as type II collagen (Col2a1)+ cells residing in
proximity to the growth plate or parathyroid hormone-related
protein (PTHrP)+ resting chondrocytes as demonstrated
previously15,16.
Cxcl12-creER+ BMSCs marked by Cxcl12-creER remained in
the marrow space predominantly as Cxcl12-GFPhigh reticular
cells (Fig. 3e). Quantiﬁcation of Cxcl12CE-8 W cells revealed that
these cells did not change in number within the marrow space
over time through 1 y 6 M (Fig. 3f). Importantly, Cxcl12-creERmarked stromal cells, regardless of the time they were marked
((i.e., Cxcl12CE-P3, Cxcl12CE-P21, Cxcl12CE-8 W, and Cxcl12CE5 M cells), made virtually no contribution to cortical osteoblasts
during the prolonged chase until 1 y 6 M (Fig. 3g–l, Supplementary Fig. 8a, b). Interestingly, these cells contributed to a fraction
of trabecular osteoblasts/cytes (Fig. 3j–l). The fraction of
Cxcl12CE-8 W cells among Col1(2.3 kb)-GFP+ trabecular osteoblasts/cytes increased progressively during the ﬁrst 6 months of
chase and reached the plateau thereafter (Fig. 3l red line). By
contrast, essentially no Cxcl12CE-8 W cells contributed to cortical
osteoblasts/cytes during the entire duration of chase (Fig. 3l, blue

Cortical bone regenerative responses of Cxcl12-creER+
BMSCs. Subsequently, we asked whether quiescent Cxcl12creER+ BMSCs can participate in skeletal regeneration. The
Cxcl12-creER line described here gives us the opportunity to
experimentally interrogate their potential to participate in cortical
bone regeneration, as quiescent Cxcl12-creER+ BMSCs do not
normally differentiate into cortical bone osteoblasts. For this
purpose, we utilized a drill-hole cortical injury model17 (Fig. 4a)
that disrupts the femoral cortical bone and the endosteal surface
to induce cortical bone regeneration through intramembranous
ossiﬁcation. We performed the surgery at 1 week after Cxcl12creER; R26RtdTomato mice carrying either Col1(2.3 kb)-GFP or
Cxcl12GFP/+ reporter were pulsed at 6–10 weeks of age (Fig. 4b).
After 2 days of injury, a substantial portion of Cxcl12CE-tdTomato+ cells adjacent to the injury site proliferated (EdU+ cells:
59.1 ± 10.8% of tdTomato+ cells, compared to 0.3 ± 0.7% in the
intact site, n = 7), and invaded into the defect while maintaining
Cxcl12-GFP expression (Fig. 4c–e). Cxcl12CE-tdTomato+ cells
continued to increase at the injury site, and occupied the intertrabecular space of newly formed woven bones (hard callus) in
the cortical bone after seven days of injury (Day 7, Fig. 4f);
particularly those within the hard callus started to express Col1
(2.3 kb)-GFP at this stage (Fig. 4g). After two weeks of injury, a
majority of Cxcl12CE-tdTomato+ cells differentiated into Col1
(2.3 kb)-GFP+ osteoblasts within the healing cortical bone (Day
14, Fig. 4h, i). After 8 weeks of injury, Cxcl12CE-tdTomato+ cells
robustly contributed to osteocytes in the regenerated portion of
the cortical bone (Day 56, Fig. 4j, k), which was not observed in
the intact portion of the cortical bone (Cxcl12CE-tdTomato+
osteocytes: 0.1 ± 0.2% in Intact, 39.7 ± 1.9% in Injured, Fig. 4l, m).
Therefore, quiescent Cxcl12-creER+ BMSCs in the marrow space
can be recruited to a cortical defect in response to injury and
differentiate into osteoblasts/cytes during cortical bone repair,
unlike in homeostasis.
Multiple types of mesenchymal cells can participate in bone
repair by becoming osteoblasts18. To address whether other
osteoblast precursor cells can participate in cortical bone
regeneration, we further took advantage of an osterix (Osx)creER line19. We performed the surgery at 1 week after osteocalcin
(Ocn)-GFP; Osx-creER; R26RtdTomato mice were pulsed at
6–10 weeks of age, and analyzed these mice after 8 weeks of
injury. OsxCE-tdTomato+ cells moderately contributed to

4

NATURE COMMUNICATIONS | (2020)11:332 | https://doi.org/10.1038/s41467-019-14029-w | www.nature.com/naturecommunications

ARTICLE

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-14029-w

a
Cxcl12-GFP+
5858 cells

Periosteal
Thy1+Ctsk +

3

Min

Max

6
UMAP_2

1
tdTomato
0

4

PreOB
Alpl +

2
7

Endothelial

Reticular
Adipoq +

Gpr182

+

8

4
3
2
1
0
Adipoq
C

UMAP_1

b

Alpl

tdTomato

Cd34 +
Expression level

5

0

1

2
Pct.exp
25

Biological replicate 1 – mouse #1: 2028 cells

50

C-0

75

C-1
100

Biological replicate 2 – mouse #2: 3830 cells
C-0

Exp.level
Mouse#1

C-1

c

Cxcl12-creER; R26R tdTomato

7

n

Sp

st

r
Po

h1

c1
le

Min

Max

C

Pt

1a

pr
Le

pb
eb
C

Fg

II7

f7

1
fs

f1

tl

C

Tn

Ki

xc

l1

2

Mouse#2

f

Ubc-creER; R26R tdTomato

Cxcl12-creER-tdTomato+
Adipogenic

Cxcl12CE-P21

UbcCE-P21

MB

+

Tomato colonies

CFU-Fs

Cont

MB

+

Tomato colonies

LipidTox/Cxcl12CE-P21

CFU-Fs

OilRed O

Osteogenic

e

Tomato+ colonies
to total CFU-Fs (%)

**
100

50

0
Cxcl12CE UbcCE

Survival rate of clones (%)

d

100

Cxcl12CE

80

UbcCE

Cont

Col1(2.3 kb)/Cxcl12CE-P21

60
40

Alizarin red

Chondrogenic

p = 0.0009

20
0
0

2

4
6
Passage

8

10
Cont

Alcian blue

osteocytes in the regenerated portion of the cortical bone (OsxCEtdTomato+ osteocytes: 12.3 ± 4.9%, Fig. 4m, n). These data
suggest that Osx-creER+ cells might be one of other progenitor
populations that contribute to approximately 60% of osteocytes in

the regenerated portion that are not derived from Cxcl12-creER
+ BMSCs.
As expected, Cxcl12-creER-marked stromal cells readily
became marrow adipocytes. Cxcl12CE-8 W and Cxcl12CE-5 M
cells spontaneously differentiated into Perillipin+ marrow
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Fig. 2 Single-cell characterization of Cxcl12-creER+ BMSCs. a Single-cell RNA-seq analysis, UMAP-based visualization of major classes of Cxcl12-GFP+
cells (Clusters 0–8). Red dotted contour: reticular cells (Cluster 0). Center panels: tdTomato expression, feature plot (top), violin plot (Clusters 0–2)
(bottom). Right panels: feature plots. Blue: high expression. n = 5858 cells merged from two biological replicates (Mouse #1: 2028 cells, Mouse #2: 3830
cells). b Split-dot-based visualization of representative gene expression in Cluster 0 (C-0, reticular cells) and Cluster-1 (C-1, pre-osteoblasts). Upper:
Mouse #1, Lower: Mouse #2. Circle size: percentage of cells expressing a given gene in a given cluster (0–100%), color density: expression level of a given
gene. c–f CFU-F assay. c Cxcl12CE-tdTomato+ (left) and UbcCE-tdTomato+ (right) bone marrow cells at P28 (pulsed at P21). Scale bar: 5 mm. d percentage
of tdTomato+ colonies among total CFU-Fs. n = 4 (Cxcl12CE), n = 7 (UbcCE) mice. **p < 0.01, two-tailed, Mann–Whitney’s U test. Data are presented as
mean ± s.d. e Survival curve of individual tdTomato+ clones over serial passages. n = 26 (Cxcl12CE), n = 48 (UbcCE) clones. Gehan–Breslow–Wilcoxon test.
f In vitro trilineage differentiation assay of Cxcl12CE-tdTomato+ clones (Passage 2–7). Upper panels: Adipogenic conditions. LipidTOX staining (left).
Green: LipidTOX-Alexa488, red: tdTomato. Oil red O staining (Right). Center panels: Osteogenic conditions. Green: Col1(2.3 kb)-GFP, red: tdTomato.
Alizarin Red staining (right). Lower panel: Chondrogenic conditions, Alcian Blue staining. Insets: differentiation medium negative controls. Scale bar:
200 µm. n = 12 clones. Source data are provided as a Source Data ﬁle.

adipocytes after the long chase, at 3 M and 1 y 6 M, respectively
(Supplementary Fig. 5a). In addition, Cxcl12-creER+ reticular
cells became marrow adipocytes in the presence of high-fat diet
containing PPARγ agonist rosiglitazone (Rosi) (LipidTOX+tdTomato+ cell: Rosi, 39.3 ± 14.6 vs. Cont, 2.5 ± 1.0 cells per section,
Supplementary Fig. 5b–e). A committed adipogenic subset of
LepR+CXCL12+ cells in the marrow space is involved in bone
fracture healing20. We, therefore, performed a tibial complete
fracture experiment, a defect of which is repaired primarily
through endochondral ossiﬁcation. We performed the surgery at
1 week after Col1(2.3 kb)-GFP; Cxcl12-creER; R26RtdTomato mice
were pulsed at 6–10 weeks of age (Supplementary Fig. 5f). After
2 weeks of fracture, Cxcl12CE-tdTomato+ cells increased
substantially within the fracture callus and became a number of
Sox9+ cells (Supplementary Fig. 5g), indicating that Cxcl12creER+ cells can differentiate into chondrocytes during fracture
healing.

appeared to induce a shift in cell populations toward preosteoblasts and osteoblasts; ABL cells were more prominent in
these osteoblastic clusters (Fig. 6c, yellow arrowheads). Concomitantly, cells in both reticular and pre-osteoblastic clusters
appeared to undergo upregulation of osteoblast-signature genes
in response to injury (Fig. 6d). Analysis of the second biological
replicate showed a pattern similar to the ﬁrst replicate
(Supplementary Fig. 6a, b). In addition, a colony-forming assay
revealed that marrow ablation induced a signiﬁcant increase in
Cxcl12CE-tdTomato+ CFU-Fs ex vivo (tdTomato+ colony:
CONT: 1.4 ± 1.1% vs. ABL: 10.5 ± 6.5% of total CFU-Fs, Fig. 6e,
f), consistent with a shift in cell populations toward preosteoblasts in the ablated marrow identiﬁed by the single cell
RNA-seq analysis. Therefore, Cxcl12-creER+ BMSCs undergo a
transcriptional change that drives them for an osteoblast-like state
in response to injury, associated with an increase in colonyforming activities.

Injury-induced identity conversion of Cxcl12-creER+ BMSCs.
We subsequently set out to deﬁne the mechanism underlying the
regenerative capacity of Cxcl12-creER+ BMSCs. For this purpose,
we investigated how injury induces change in cell populations
and their transcriptomes of quiescent Cxcl12-creER+ BMSCs by
combined lineage-tracing and single cell RNA-seq analyses. As an
injury model, we made use of a femoral bone marrow ablation
model that mechanically removes a deﬁned area of bone marrow
using an endodontic instrument21 (Fig. 5a, b). This procedure
induces direct differentiation of marrow stromal cells within the
marrow cavity without involving the periosteum. The right femur
underwent the surgery, while the left femur was untreated and
used as an internal control (Fig 5a). Marrow ablation induced
differentiation of Cxcl12CE-tdTomato+ cells into Col1a1(2.3 kb)GFP+ osteoblasts within the marrow space (Fig. 5c–j, Supplementary Fig. 8a, b).
We interrogated the single-cell proﬁle of lineage-marked
Cxcl12CE-tdTomato+ cells from the ablated (ABL) and the
contralateral control femur (CONT) individually after 7 days of
marrow ablation, followed by integration of two datasets using
Seurat/CCA22 (Fig. 6a, Supplementary Fig. 8c, e). Initial analysis
revealed that a substantial fraction of cells belonged to the clusters
without detectable tdTomato expression; these tdTomatoneg
clusters included myeloid cells, lymphocytes and erythroid cells
(Supplementary Fig. 6a). tdTomato was predominantly expressed
by mesenchymal cells expressing Cxcl12 or Col1a1, but also by a
small number of endothelial cells. A graph-based clustering
analysis of integrated mesenchymal Cxcl12CE-tdTomato+
cells revealed 12 clusters, including three major groups of
Cxcl12+Adipoq+ reticular cells (Clusters 0–2) and small groups
of Alpl+ osteoblastic cells (Clusters 4 and 6); a terminally
differentiated osteoblast marker Iﬁtm5 was exclusively expressed
by cells in Cluster 4 (Fig. 6b). Most notably, marrow ablation

Cxcl12-creER+ BMSCs transform into skeletal stem-like cells.
Further, we set out to deﬁne the functional importance of Cxcl12creER+ BMSCs in cortical bone regeneration by inducible cell
ablation experiments using a Rosa26-iDTA (inducible diphtheria
toxin fragment A) allele. Flow cytometry analysis of Cxcl12-creER;
Rosa26lsl-tdTomato/+ (tdT) and Cxcl12-creER; Rosa26lsl-tdTomato/iDTA
(DTA) littermates at 16 weeks of age after being pulsed at 4, 6,
and 8 weeks of age revealed a 6.8-fold reduction of tdTomato+
cells in DTA mice (tdTomato+ cells: tdT, 0.045 ± 0.004% vs.
DTA, 0.007 ± 0.006% of CD45/Ter119/CD31neg fraction, Fig. 7a,
Supplementary Fig. 8a, n = 3 for Control, n = 6 for DTA mice),
demonstrating the effectiveness of an iDTA-mediated cell ablation approach. Subsequently, we pulsed Rosa26lsl-tdTomato/iDTA
(Control) and Cxcl12-creER; Rosa26lsl-tdTomato/iDTA (DTA) littermates with tamoxifen at 4 weeks of age, and performed the
surgery at 1 week after the pulse. After 14 days of injury, bone
volume and bone mineral density of the injured cortical area were
signiﬁcantly reduced in DTA mice (Fig. 7b, c). Therefore,
quiescent Cxcl12-creER+ BMSCs are a functionally important
contributor to cortical bone regeneration.
Further, we aimed to deﬁne how quiescent Cxcl12-creER+
BMSCs can be activated and embark on the differentiation
trajectory into osteoblasts. For this purpose, we examined the
single cell proﬁle of lineage-marked Cxcl12CE-tdTomato+ cells
from the ablated femur after 14 days of marrow ablation (Fig. 7d,
Supplementary Fig. 8c, e). Initial analysis revealed again that a
substantial fraction of cells (7074/9469 cells) belonged to the
clusters without detectable tdTomato expression. A graph-based
clustering analysis of mesenchymal Cxcl12CE-tdTomato+ cells
revealed that pre-osteoblasts (preOBs) appeared as an intermediate state between Cxcl12+Adipoq+ perisinusoidal reticular
cells and Bglap+ mature osteoblasts (Fig. 7e, Supplementary
Fig. 7a–c). These intermediate-state cells expressed Itgav
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(encoding CD51) and Cd200 (CD200), but not Thy1 (CD90),
Eng (CD105), Grem1 (Grem1), or Ly6a (Sca1), indicating that
these cells might overlap with previously reported mouse SSCs
(mSSCs)23, but not with osteo-chondro-reticular stem cells24
(Fig. 7f). We further constructed an unsupervised single-cell
trajectory using Monocle (Supplementary Fig. 7d). This analysis
predicted a continuous lineage path without a branch, and
empirically identiﬁed pseudotime-dependent genes that were
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highly expressed in populations corresponding to perisinusoidal
reticular cells, pre-osteoblasts and mature osteoblasts (Fig. 7g, h).
Functional annotation of 970 pseudotime-dependent differentially expressed genes using DAVID revealed signiﬁcant enrichment of Gene Ontology terms related to Wnt signaling (3 out of
top 7 most signiﬁcant terms, Wnt signaling pathway
[GO:0016055], negative regulation of Wnt [GO:0030178] and
canonical Wnt [GO:0090090] signaling pathway) (Fig. 7i). In fact,
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Fig. 3 Cell-fate analysis reveals dormancy of Cxcl12-creER+ BMSCs. a–l Long-chase analysis of Cxcl12-creER+ cells. a–c Col1(2.3 kb)-GFP; Cxcl12-creER;
R26RtdTomato distal femurs with growth plates on top, analyzed at 1Y. Pulsed at P3 (a), P21 (b), and 8 W (c). Yellow double arrows: tdTomatoneg area
beneath growth plates, white brackets: tdTomato+ domain in marrow space. Scale bar: 500 µm. Gray: DIC. d Quantiﬁcation of tdTomato+ reticular cells in
marrow space at 1Y, based on distance from growth plate. Pulsed at P3 (blue line), P21 (green line) or 8 W (red line). n = 6 (P3, P21-pulsed), n = 5 (8Wpulsed) mice. e Cxcl12GFP/+; Cxcl12-creER; R26RtdTomato bone marrow at 1 y (pulsed at P21), central marrow space. Gray: DAPI. Scale bar: 20 µm. n = 3 mice.
f Quantiﬁcation of tdTomato+ reticular cells in marrow space during extended chase, pulsed at 8 W. n = 4 (9 W), n = 5 (3 M), n = 3 (6 M, 1 y, and 1 y 6 M)
mice. g Col1(2.3 kb)-GFP; Cxcl12-creER; R26RtdTomato bone marrow at 1 y (pulsed at P21), endosteal space. Scale bar: 20 µm. n = 4 mice. h Percentage of
Col1(2.3 kb)-GFP+tdTomato+ cells per total Col1(2.3 kb)-GFP+ cortical bone osteoblasts. (Left): ﬂow cytometry. n = 4 (+1 W), n = 3 (+8 W) mice.
(Right): labeled at P3, P21, 8 W, and 5 M, analyzed at 1 y 6 M. OB osteoblasts, OCY osteocytes. n = 3 per group. i Col1(2.3 kb)-GFP; Cxcl12-creER;
R26RtdTomato distal femurs at 9 W (pulsed at 8 W). 1 (endosteal area): boxed area on left panel. Gray: DIC. Scale bar: 500 µm (left), 20 µm (right). n = 3
mice. j Cxcl12-creER; R26RtdTomato distal femur bone marrow at 1Y (pulsed at 8 W). Lower left panel: central marrow space with Cxcl12GFP/+, right panels:
endosteal space and trabecular bone with Col1(2.3 kb)-GFP. Gray: DIC. Scale bar: 20 µm. n = 3 mice. k, l Percentage of Col1(2.3 kb)-GFP+tdTomato+ cells
per total Col1(2.3 kb)-GFP+ cells by using ﬂow cytometry (k). n = 3 (+2 days), n = 4 (+1 W), n = 7 (+4 W) and n = 6 (+8 W) mice. l Labeled at 8 W,
analyzed at 9 W, 3 M, 6 M, 1 y, and 1 y 6 M. n = 3 (9 W, 3 M, 1 y, and 1 y 6 M), n = 4 (6 M) mice. ****p < 0.0001, ***p < 0.001, two tailed, one-way ANOVA
followed by Tukey’s post hoc test (f, h, k, l). Two-tailed, Mann–Whitney’s U test (h). All data are presented as mean ± s.d. Source data are provided as a
Source Data ﬁle.

genes encoding soluble Wnt antagonists including Sfrp1, Sfrp2
and Sfrp4 were enriched in perisinusoidal reticular cells, whereas
Ctnnb1, a key component of Wnt/β-catenin signaling, was
enriched in pre-osteoblasts. Therefore, quiescent Cxcl12-creER+
BMSCs appear to undergo activation of canonical Wnt signaling
during their transition into pre-osteoblasts.
Wnt-mediated transformation orchestrates bone regeneration.
To test the hypothesis that canonical Wnt signaling plays an
important role in this transition, we conditionally deleted
β-catenin (Ctnnb) in Cxcl12-creER+ BMSCs during cortical bone
regeneration, using Cxcl12-creER; Ctnnb+/+; R26RtdTomato
(Control), Cxcl12-creER; Ctnnbﬂ/+; R26RtdTomato (βCat cHet) and
Cxcl12-creER; Ctnnbﬂ/ﬂ; R26RtdTomato (βCat cKO) littermates.
After 14 days of cortical bone injury, bone volume and bone
mineral density of the injured cortical area were signiﬁcantly
reduced in βCat cKO mice compared with Control or βCat cHet
mice, associated with reduction in alkaline phosphatase (ALP)+
cells (Fig. 8a, b). The reduction of bone volume in βCat cKO mice
was comparable to that of DTA mice, indicating that canonical
Wnt signaling plays essential functional roles in Cxcl12-creER+
BMSCs’ differentiation trajectory toward osteoblasts.
Transcription factors Sox9 and Runx2 cooperatively regulate
commitment to the osteoblast lineage in a manner regulated by
canonical Wnt signaling during skeletal development25,26. However, our analysis showed that Sox9 expression was unaltered,
while Runx2 expression was not consistently altered in response
to injury (Fig. 6d). To test whether Sox9 and Runx2 play roles in
cell identity conversion, we conditionally deleted Sox9 or Runx2
in quiescent Cxcl12-creER+ BMSCs during cortical bone
regeneration, using Cxcl12-creER and ﬂoxed alleles for Sox9 and
Runx2. After 14 days of cortical bone injury, bone volume and
bone mineral density of the injured cortical area was not altered
in Sox9 cKO mice or in Runx2 cKO mice (Fig. 8c), indicating that
their transition into pre-osteoblasts is not regulated by Sox9
or Runx2.
Further, to address whether high levels of β-catenin can inhibit
osteoblast differentiation of Cxcl12-creER+ BMSCs during
cortical bone regeneration, we conditionally induced haploinsufﬁciency of adenomatous polyposis coli (Apc), which is a critical
component of the β-catenin degradation complex, during cortical
bone regeneration using Cxcl12-creER; Apc+/+; R26RtdTomato
(Control) and Cxcl12-creER; Apcﬂ/+; R26RtdTomato (Apc cHet)
littermates. After 7 days of cortical bone injury, there was no
signiﬁcant change in bone volume and bone mineral density of
the injured cortical area in Apc cHet mice (Fig. 8d). Therefore, a
high level of β-catenin in Cxcl12-creER+ BMSCs due to APC
8

haploinsufﬁciency does not inhibit their osteoblast differentiation
during cortical bone regeneration. A limitation of this approach is
that it provides a different level of β-catenin stabilization than
removing the phosphorylation sites encoded by exon 3.
Canonical Wnt signaling plays disparate roles in different
phases of bone fracture repair27. To determine whether Cxcl12creER+ cells are more or less sensitive to β-catenin than other
fracture repair sources, we conditionally deleted Ctnnb in
osteoblast precursor cells during cortical regeneration, using
Ctnnbﬂ/ﬂ; R26RtdTomato (Control) and Dlx5-creER; Ctnnbﬂ/ﬂ;
R26RtdTomato (Dlx5-βCat cKO) littermates. After 14 days of
cortical bone injury, bone volume and bone mineral density of the
injured cortical area were signiﬁcantly reduced Dlx5-βCat cKO
mice compared with Control mice (Fig. 8e, f). Therefore, Cxcl12creER+ BMSCs are equally as sensitive to β-catenin as Dlx5creER+ osteoblast precursor cells.
Taken together, our ﬁndings provide functional evidence that
quiescent Cxcl12-creER+ BMSCs orchestrates cortical bone
regeneration in a unique manner mediated by canonical Wnt
signaling independent of Sox9 or Runx2 function.
Discussion
Here, we identiﬁed that quiescent Cxcl12-creER+ BMSCs can
convert their identity into a precursor cell state similar to SSCs
during injury responses in a manner mediated by canonical Wnt
signaling, and substantially contribute to skeletal regeneration
(see Fig. 9a–c). Importantly, these Cxcl12-creER+ BMSCs show
little colony-forming activities and do not contribute to cortical
bone osteoblasts in homeostasis or new CXCL12+ cells in
growing marrow space, therefore representing a speciﬁc quiescent
subpopulation of LepR+CXCL12+ BMSCs marked by LepR-cre
or Ebf3-creER7,9. LepR+CXCL12+ cells that contribute to cortical
bone osteoblasts in physiological conditions are within the
majority of perisinusoidal cells that are not marked by Cxcl12creER. Injury-induced cues drive these Cxcl12-creER+ BMSCs
into a reticular-osteoblast hybrid state associated with global
upregulation of osteoblast-signature genes. Our ﬁndings support
the theory that canonical Wnt-mediated cellular plasticity
underpins the remarkable regenerative capacity of CXCL12+
BMSCs. Canonical Wnt signaling is widely known as the central
regulator of osteogenesis, particularly during early skeletal
development25,26. In adult bones, canonical Wnt signaling prevents a cell fate shift of preosteoblasts to adipocytes28 and inhibits
excessive osteoclastogenesis through regulating mature osteoblasts29. In addition, liposomal delivery of Wnt proteins can
promote bone regeneration30. Our ﬁndings highlight a mechanism that canonical Wnt signaling facilitates osteogenesis by
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transforming CXCL12+ BMSCs into osteoblast precursor cells
particularly under regenerative conditions. CXCL12+ BMSCs are
equally as sensitive to deﬁciency in canonical Wnt signaling as
other osteoblast precursor cells. This Wnt-mediated mechanism

appears to be unique because, unlike in skeletal development, it
does not mediate Sox9 or Runx2 function.
The remarkable regenerative potential of bones is generally
attributed to rare SSCs. Our ﬁndings raise an intriguing possibility that the previously deﬁned SSCs23 can be generated through
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Fig. 4 Cortical bone regenerative responses of Cxcl12-creER+ BMSCs. (a–n) Fates of Cxcl12-creER+ cells or Osx-creER+ cells during cortical bone
regeneration after drill-hole injury. a Experimental schemes for drill-hole cortical injury model. b Timeline for tamoxifen injection, drill-hole injury and
analysis. Cxcl12GFP/+; Cxcl12-creER; R26RtdTomato (c, f) or Col1(2.3 kb)-GFP; Cxcl12-creER; R26RtdTomato (g–k) femur diaphyseal cortical bones (pulsed at
7 days before surgery) with periosteum on top. CB cortical bone, BM bone marrow. Gray: DIC. n = 5 mice per each group. c, d Injured area at 2 days after
injury, femurs with EdU administration shortly before analysis. Scale bar: 200 µm (c), 50 µm (d). e Quantiﬁcation of EdU+tdTomato+ cells. n = 6 (Intact),
n = 7 (Injured). EdU was administered twice (6 and 3 h) prior to analysis. **p < 0.01, two-tailed Mann–Whitney’s U test. f, g Injured area at 7 days after
injury, femurs with EdU administration shortly before analysis. Scale bar: 200 µm (f), 20 µm (g). h, i Injured area at 14 days after injury, femurs with EdU
administration shortly before analysis. Scale bar: 200 µm (h), 20 µm (i). j–l Injured cortical bone at 56 days after injury. Scale bar: 200 µm (h, l), 20 µm (i).
m Number of tdTomato+ cells within intact and injured are of Cxcl12-creER; R26RtdTomato cortical bone (blue and red dots, respectively) or injured area of
Osx-creER; R26RtdTomato cortical bone (orange dots). n = 5 mice per group. **p < 0.01, two-tailed, Mann–Whitney’s U test. n Injured cortical bone at 56 days
after injury, Ocn-GFP; Osx-creER; R26RtdTomato femurs. All data are presented as mean ± s.d. Source data are provided as a Source Data ﬁle.
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Fig. 6 Injury-induced identity conversion of Cxcl12-creER+ BMSCs. a–d Single-cell RNA-seq analyses of lineage-traced Cxcl12-creER+ cells. a Cxcl12CEtdTomato+ cells were isolated from contralateral (CONT) and ablated (ABL) femurs separately at 7 days after marrow ablation. Two datasets were
integrated by Seurat/CCA. b, c UMAP-based visualization of major classes of mesenchymal Cxcl12CE-tdTomato+ cells (Cluster 0–11). Left panel, red
dotted contour: reticular (Clusters 0–2). Lower panels: feature plots. Blue: high expression. Right panel: cells colored by conditions (CONT, ABL). Biological
replicate 1, n = 2939 cells (CONT: 2066 cells, ABL: 873 cells), pooled from n = 7 mice. d Split-dot-based visualization of representative gene expression.
Clusters 0 and 1 (reticular) and Cluster 6 (pre-osteoblast) shown for reticular-signature genes (Cxcl12, Adipoq) and osteoblast-signature genes (Col1a1,
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Data ﬁle.

transformation of mature stromal cells. This is reminiscent of a
model proposed in the adult liver and pancreas, both of which
possess high regenerative capacity despite slow cell turnover;
these organs primarily depend on mature cells for tissue maintenance in homeostasis and regeneration in response to injury31.
We assume that mature stromal cells abundantly available in the
milieu provide the primary source of cells executing bone repair
under markedly slow cell turnover in the adult bone, in conjunction with a small number of resident osteoblast precursor
cells. These highly malleable, long-living mature stromal cells

readily available throughout the lifespan represent an ideal cellular source for tissue regeneration. Further mechanistic studies
are needed to exploit these cells better for future regenerative
medicine.
Methods

Generation of Cxcl12-creER BAC transgenic mice. Cxcl12-iCreERT2-bGHpA
transgenic mice were generated by pronuclear injection of a modiﬁed BAC clone
RP23-22F6 (Children’s Hospital Oakland Research Institute, Oakland, CA) containing 74 kb upstream and 121 kb downstream genomic sequences of the Cxcl12
gene. Hybrid primers (Fw: ACTTTCACTCTCGGTCCACCTCGGTGTCCTC
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sequence. The PCR product was gel-puriﬁed prior to electroporation into Escherichia coli strain SW105 containing RP23-22F6. Recombinants were selected on
bacterial plates containing kanamycin and PCR-screened for homologous recombination events, followed by pulsed-ﬁeld gel electrophoresis analysis (CHEF-DRIII,
Bio-rad) to conﬁrm no gross rearrangement of the targeted BAC clones. The
sequence of the BAC-insert junction was further validated based on PCR. The
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Fig. 7 Cxcl12-creER+ BMSCs transform into a skeletal stem cell-like state. a Inducible partial cell ablation of Cxcl12-creER+ stromal cells using an
inducible diphtheria toxin fragment A (DTA) allele. Flow cytometry-based veriﬁcation of iDTA-mediated cell ablation of Cxcl12-creER+ stromal cells. n = 3
(tdT), n = 6 (DTA) mice. *p < 0.05, two-tailed, Mann–Whitney’s U test. b, c DTA-mediated ablation of Cxcl12-creER+ cells during cortical bone
regeneration. Rosa26lsl-tdTomato/iDTA (Control) and Cxcl12-creER; Rosa26lsl-tdTomato/iDTA (DTA) femur diaphyseal cortical bones, 14 days after cortical drillhole surgery (pulsed at 7 days before surgery). b Cortical bone injured areas. Upper panels: alkaline phosphatase (ALP) staining. Gray: DIC. Scale bar:
200 µm. Lower panels: 3D-µCT. Scale bar: 1 mm. c Bone volume/tissue volume (BV/TV, left) and bone mineral density (BMD, right) of the injured area.
n = 6 (Control), n = 4 (DTA) mice. **p < 0.01, two-tailed, Mann–Whitney’s U test. d–i Single-cell RNA-seq analyses of lineage-traced Cxcl12-creER+ cells.
Cxcl12CE-tdTomato+ cells were isolated from ablated (ABL) femurs at 14 days after marrow ablation. e UMAP-based visualization of major classes of
mesenchymal Cxcl12CE-tdTomato+ cells (Clusters 0–9). Red dotted contour: reticular cells, green dotted contour: preosteoblasts. n = 1825 cells pooled
from n = 7 mice. f Feature plots of skeletal stem cell marker genes. g Heatmap of representative pseudotime-dependent genes. h Pseudotime and single
cell trajectory analysis by Monocle. i Most signiﬁcant Gene Ontology (GO) terms (Biological Process) based on DAVID functional annotation of
differentially expressed genes (DEGs). Black: general, red: Wnt signaling-related, blue: bone-related terms. All data are presented as mean ± s.d. Source
data are provided as a Source Data ﬁle.

NeoR cassette was removed from correctly targeted BAC clones by L-arabinose
induction of ﬂpe recombinase, and lox sites (loxP and lox511) in the BAC plasmid
were replaced with AmpR and NeoR cassettes by recombineering. The modiﬁed
BAC clone was veriﬁed by pulsed-ﬁeld gel electrophoresis analysis, and puriﬁed by
NucleoBond Xtra BAC puriﬁcation kit (Clontech). The BAC clone was linearized
by BsiWI digest, and a 207 kb fragment containing Cxcl12-iCreERT2-bGHpA was
separated by size-exclusion chromatography (Sepharose CL-4B). The fragment
eluted from the column was collected in multiple fractions in polyamine microinjection buffer to protect the DNA from shearing, followed by pulsed-ﬁeld gel
electrophoresis analysis. The concentration of the BAC construct was veriﬁed on
Nanodrop 2000 spectrophotometer. The BAC clone was microinjected into
B6SJLF1 fertilized eggs at a concentration of 0.25-0.5 ng/µl. Genomic DNA from
potential founders were genotyped with PCR primers (320: TTTCACTCTCG
GTCCACCTC, 321: GGATCTGCACACAGACAGGA), in which one primer is
designed external to homology arms while another primer is designed internal to
the transgene. Generic iCre primers (322: GTGCAAGCTGAACAACAGGA, 323:
CCAGCATCCACATTCTCCTT) were also used. The founder mice were backcrossed with C57/BL6 mice at least for four generations before analysis. The three
lines were established; Line274, Line277, and Line289. Line274 showed no
recombination in bone marrow stromal cells when bred to an R26R-tdTomato
allele and exposed to tamoxifen; tdTomato+ cells were exclusively discovered in the
articular cartilage and its surrounding tissues. Line277 showed extensive
tamoxifen-independent recombination when bred to an R26R-tdTomato allele.
Line289 showed no tamoxifen-independent recombination in the stromal cell
compartment when bred to an R26R-tdTomato allele, and bone marrow stromal
cells were marked in response to tamoxifen administration. Therefore, Line289 was
used for this study.
Mice. Cxcl12GFP/+ 6 and Osx-creER19 mice have been described previously.
Rosa26-CAG-loxP-stop-loxP-tdTomato (Ai14: R26R-tdTomato, JAX007914),
Col1a1(2.3 kb)-GFP (JAX013134), osteocalcin (Ocn)-GFP (JAX017469), Ubc-creER
(JAX007001), Dlx5-creER (JAX010705), Rosa26-SA-loxP-GFP-stop-loxP-DTA
(JAX006331), Ctnnb-ﬂoxed (JAX004152), Apc-ﬂoxed (JAX009045), and Sox9ﬂoxed (JAX013106)32 mice were acquired from the Jackson laboratory. Runx2ﬂoxed mice33 were provided from Dr. Cecilia Giachelli. All procedures were
conducted in compliance with the Guidelines for the Care and Use of Laboratory
Animals approved by the University of Michigan’s Institutional Animal Care and
Use Committee (IACUC), protocol 7681 (Ono) and 8779 (Kozloff). All mice were
housed in a speciﬁc pathogen-free condition, and analyzed in a mixed background.
For all breeding experiments, creER transgenes were maintained in male breeders
to avoid spontaneous germline recombination. Mice were identiﬁed by microtattooing or ear tags. Tail biopsies of mice were lysed by a HotShot protocol
(incubating the tail sample at 95 °C for 30 min in an alkaline lysis reagent followed
by neutralization) and used for PCR-based genotyping (GoTaq Green Master Mix,
Promega, and Nexus X2, Eppendorf). Perinatal mice were also genotyped ﬂuorescently (BLS miner’s lamp) whenever possible. Mice were euthanized by overdosage of carbon dioxide or decapitation under inhalation anesthesia in a drop jar
(Fluriso, Isoﬂurane USP, VetOne).
Tamoxifen. Tamoxifen (Sigma T5648) was mixed with 100% ethanol until completely dissolved. Subsequently, a proper volume of sunﬂower seed oil (Sigma
S5007) was added to the tamoxifen-ethanol mixture and rigorously mixed. The
tamoxifen-ethanol-oil mixture was incubated at 60oC in a chemical hood until the
ethanol evaporated completely. The tamoxifen-oil mixture was stored at room
temperature until use. Tamoxifen was injected to mice intraperitoneally using a 261/2-gauge needle (BD309597).
High fat diet containing rosiglitazone. Mice were fed with a high-fat diet containing 20 mg/kg rosiglitazone (D10010301, 60 kcal%, Research Diets) for 6 weeks.

Surgery. Mice were anesthetized through a nose cone, in which 1.5–2% isoﬂurane
was constantly provided with oxygen through a vaporizer.
For drill-hole injury, left femurs were operated, while right femurs were
untreated and used as an internal control. An incision was made in the lateral skin
of the mid-femur. After splitting the muscle, the periosteum was separated to
expose the femoral surface. A drill-hole injury was made onto the diaphysis by a
Micro-Drill (Stoelting) with a 0.9 mm diameter stainless steel burr (Fine Science
Tools). The periosteum of the surgical ﬁeld was scraped off using a scalpel prior to
the procedure.
For bone marrow ablation surgery, right femurs were operated, while left
femurs were untreated and used as an internal control. After skin incision, cruciate
ligaments of the knee were carefully separated using a dental excavator, and a hole
was made in the intercondylar region of femurs using a 26-1/2-gauge needle
(BD309597). The endodontic instruments (K-ﬁle, #35, 40, 45, and 50) (GC, Tokyo,
Japan) were used in a stepwise manner to remove a cylindrical area of the marrow
space. The surgical ﬁeld was irrigated with saline, and the incision line was sutured.
For tibial complete fracture healing model, legs were aseptically prepared using
Chlorhexidine scrub, once mice were anesthetized. A small incision was made on
the anterior-medial surface of the proximal tibial metaphysis, exposing the knee
joint and patellar tendon. Using a small gauge needle, an entry hole was made
distally through the proximal tibial condyles, through which a narrow stainless
steel wire was placed and extended through the intramedullary canal until contact
at the distal end. The pin was trimmed ﬂush with the proximal tibial condyles, and
skin and soft tissue are closed with suture. While remaining under anesthesia,
animals were positioned under a custom-built guillotine apparatus such that upon
impact, a transverse fracture was made at the mid-distal tibial diaphysis. Tibias
were gently stabilized with a small length of medical tape to provide support and
biomechanical stability for immediate ambulation. Animals were subsequently
recovered and returned to housing cages.
To evaluate cell proliferation, 5-ethynyl-2′-deoxyuridine (EdU) (Invitrogen
A10044) dissolved in phosphate-buffered saline (PBS) was administered twice (6
and 3 h) before sacriﬁce at 2, 7, and 14 days after drill-hole injury (dose per
injection: 200 µg).
Histology and immunohistochemistry. Samples were ﬁxed in 4% paraformaldehyde for a proper period, typically ranging from 3 h to overnight at 4 °C,
then decalciﬁed in 15% ethylenediaminetetraacetic acid for a proper period, typically ranging from 3 h to 14 days. Decalciﬁed samples were cryoprotected in 30%
sucrose/PBS solutions and then in 30% sucrose/PBS:OCT (1:1) solutions, each at
least overnight at 4 °C. Samples were embedded in an OCT compound (TissueTek, Sakura) and cryosectioned at 14 µm using a cryostat (Leica CM1850) and
adhered to positively charged glass slides (Fisherbrand ColorFrost Plus). Sections
were postﬁxed in 4% paraformaldehyde for 15 min at room temperature. For
immunostaining, sections were permeabilized with 0.25% TritonX/TBS for 30 min,
blocked with 3% bovine serum albumin/TBST for 30 min. and incubated with rat
anti-endomucin (Emcn) monoclonal antibody (1:100, Santa Cruz Biotechnology,
sc65495), rat anti-CD31 monoclonal antibody (1:100, Bio-Rad, MCA2388), goat
anti-leptin receptor (LepR) polyclonal antibody (1:100, R&D, AF497), goat antiosteopontin (OPN) polyclonal antibody (1:500, R&D, AF808), goat anti-ALPL
polyclonal antibody (1:100, R&D, AF2910), rabbit anti-Sox9 polyclonal antibody
(1:500, EMD-Millipore, AB5535), rabbit anti-perilipin A/B polyclonal antibody
(1:500, Sigma, P1873) or rabbit anti-PPAR gamma (PPARγ) monoclonal antibody
(1:200, Invitrogen, MA5-14889) overnight at 4 °C, and subsequently with Alexa
Fluor 633-conjugated goat anti-rat IgG (A21049), Alexa Fluor 647-conjugated
donkey anti-goat IgG (A21082), or Alexa Fluor 647-conjugated donkey anti-rabbit
IgG (A31573) (1:400, Invitrogen) for 3 h at room temperature. For EdU assay,
sections were incubated with Alexa Fluor 647-azide (Invitrogen, A10277) for
30 min at 43 °C using Click-iT Imaging Kit (Invitrogen, C10337). Sections were
further incubated with DAPI (4′,6-diamidino-2-phenylindole, 5 µg/ml, Invitrogen
D1306) to stain nuclei prior to imaging. For lipid staining, cryosections were
immediately cover-slipped with LipidTOX Deep Red (1:200, Invitrogen, H34477)
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Fig. 8 Wnt-mediated transformation orchestrates bone regeneration. a, b Functional analysis of Wnt/β-Catenin signaling in Cxcl12-creER+ cells during
cortical bone regeneration. Cxcl12-creER; Ctnnb+/+; R26RtdTomato (Control, left), Cxcl12-creER; Ctnnbﬂ/ﬂ; R26RtdTomato (βcat cKO, right) femur diaphyseal
cortical bones, 14 days after cortical drill-hole surgery (pulsed at 7 days before surgery). a Cortical bone injured areas. Upper panels: alkaline phosphatase
(ALP) staining. Gray: DIC. Scale bar: 200 µm. Lower panels: 3D-µCT. Scale bar: 1 mm. b Bone volume/tissue volume (BV/TV, left) and bone mineral
density (BMD, right) of the injured area. n = 4 (Control), n = 8 (Cxcl12-creER; Ctnnbﬂ/+; R26RtdTomato, βCat cHet) mice, n = 8 (βCat cKO) mice. c Functional
analysis of Sox9 and Runx2 in Cxcl12-creER+ cells during cortical bone regeneration. Cxcl12-creER; Sox9+/+ or Runx2+/+;R26RtdTomato (Control, left), Cxcl12creER; Sox9ﬂ/+ or Runx2ﬂ/+;R26RtdTomato (Sox9 cHet or Runx2 cHet, center) and Cxcl12-creER; Sox9ﬂ/ﬂ or Runx2ﬂ/ﬂ; R26RtdTomato (Sox9 cKO or Runx2 cKO,
right) femur diaphyseal cortical bones, 14 days after cortical drill-hole surgery (pulsed at 7 days before surgery). BV/TV (left) and BMD (right) of the
injured area. n = 7 (Sox9 Control), n = 4 (Sox9 cHet, cKO) mice. n = 6 (Runx2 Control, cKO), n = 8 (Runx2 cHet) mice. d Functional analysis of Apc in
Cxcl12-creER+ cells during cortical bone regeneration. Cxcl12-creER; Apc+/+; R26RtdTomato (Control, left), Cxcl12-creER; Apcﬂ/+; R26RtdTomato (Apc cHet,
right) femur diaphyseal cortical bones, 7 days after cortical drill-hole surgery (pulsed at 7 days before surgery). BV/TV (left) and BMD (right) of the
injured area. n = 6 (Control), n = 4 (Apc cHet) mice. e, f Functional analysis of Wnt/β-Catenin signaling in Dlx5-creER+ cells during cortical bone
regeneration. Ctnnbﬂ/ﬂ; R26RtdTomato (Control, left), Dlx5-creER; Ctnnbﬂ/ﬂ; R26RtdTomato (Dlx5-βcat cKO, right) femur diaphyseal cortical bones, 14 days
after cortical drill-hole surgery (pulsed at 7 days before surgery). e 3D-µCT. Lower panels: BV/TV (left) and BMD (right) of the injured area. Scale bar:
1 mm. n = 6 mice per group. ****p < 0.0001, ***p < 0.001, *p < 0.05, two-tailed, one-way ANOVA followed by Tukey’s post hoc test (b, c). Two-tailed,
Mann–Whitney’s U test (d, f). All data are presented as mean ± s.d. Source data are provided as a Source Data ﬁle.
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Fig. 9 A Wnt-mediated conversion of stromal cell identity orchestrates skeletal regeneration. a Quiescent CXCL12+ bone marrow stromal cells
(BMSCs) in perisinusoidal space are marked by Cxcl12-creER upon tamoxifen injection. These cells are preferentially localized in a non-endosteal location of
the marrow space, associated with a reticular morphology, abundant cytokine expression and little colony-forming activities. These cells do not become
cortical bone osteoblasts in homeostasis, but can be readily converted to marrow adipocytes. b A proposed diagram of the bone marrow stromal cell
lineage. In homeostasis, CXCL12high reticular cells and COL1A1high osteoblasts represent two opposite differentiated states of the bone marrow stromal cell
lineage. The transition between these two cell types is continuous, wherein intermediate-state cells represent a precursor cell population. c Wnt-mediated
cellular plasticity of CXCL12+ reticular cells during injury responses. In homeostasis, Cxcl12-creER+ reticular cells are in a Wnt-inhibitory state by
expressing potent Wnt inhibitors, such as Sfrp1, Sfrp2, and Sfrp4. During injury responses, Cxcl12-creER + reticular cells are brought into a reticularosteoblast hybrid state by injury-induced cues, associated with upregulation of osteoblast-signatures and a critical canonical Wnt component, β-catenin.
Subsequently, Wnt/β-catenin signaling induces cell identity conversion of Cxcl12-creER+ reticular cells into pre-osteoblasts, which are featured by a
skeletal stem cell-like state with partial commitment to the osteoblast lineage. These cells can be recruited to cortical bone defect and functionally
contribute to skeletal regeneration.
and 5 µg/ml DAPI solution and incubated for 2 h at 43 °C. Stained samples were
mounted in TBS with No. 1.5 coverslips (Fisher).
Imaging. Images were captured by an automated inverted ﬂuorescence microscope
with a structured illumination system (Zeiss Axio Observer Z1 with ApoTome.2
system) and Zen 2 (blue edition) software. The ﬁlter settings used were: FL Filter
Set 34 (Ex. 390/22, Em. 460/50 nm), Set 38 HE (Ex. 470/40, Em. 525/50 nm), Set 43
HE (Ex. 550/25, Em. 605/70 nm), Set 50 (Ex. 640/30, Em. 690/50 nm) and Set 63
HE (Ex. 572/25, Em. 629/62 nm). The objectives used were: Fluar 2.5×/0.12, EC
Plan-Neoﬂuar 5×/0.16, Plan-Apochromat 10×/0.45, EC Plan-Neoﬂuar 20×/0.50,
EC Plan-Neoﬂuar 40×/0.75, Plan-Apochromat 63×/1.40. Images were typically tile-

scanned with a motorized stage, Z-stacked and reconstructed by a maximum
intensity projection function. Differential interference contrast was used for
objectives higher than 10×. Representative images of at least three independent
biological samples are shown in the ﬁgures. Quantiﬁcation of cells on sections was
performed using NIH Image J software.
Cell dissociation. Soft tissues and epiphyses were carefully removed from dissected
femurs. After removing distal epiphyseal growth plates and cutting off proximal
ends, femurs were cut roughly and incubated with 2 Wunsch units of LiberaseTM
(Sigma/Roche 5401127001) and 1 mg of Pronase (Sigma/Roche 10165921001) in
2 ml Ca2+, Mg2+-free Hank’s Balanced Salt Solution (HBSS, Sigma H6648) at
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37 °C for 60 min. on a shaking incubator (ThermomixerR, Eppendorf). After cell
dissociation, cells were mechanically triturated using an 18-gauge needle with a
1 ml Luer-Lok syringe (BD) and a pestle with a mortar (Coors Tek), and subsequently ﬁltered through a 70 µm cell strainer (BD) into a 50 ml tube on ice to
prepare single cell suspension. These steps were repeated for ﬁve times, and dissociated cells were collected in the same tube. Cells were pelleted and resuspended
in an appropriate medium for subsequent purposes. For cell culture experiments,
cells were resuspended in 10 ml culture medium and counted on a hemocytometer.
Flow cytometry. Dissociated cells were stained by standard protocols with the
following antibodies (1:500, Invitrogen/eBioscience). eFluor450-conjugated CD31
(390, endothelial/platelet, 48-0311-82), CD45 (30F-11, hematopoietic, 48-0451-82),
Ter119 (TER-119, erythrocytes, 48-5921-82), allophycocyanin (APC)-conjugated
CD31 (390, endothelial/platelet, 17-0311-82), CD45 (30F-11, hematopoietic, 170451-82), Ter119 (TER-119, erythrocytes, 17-5921-82). For LepR staining, goat
anti-LepR polyclonal antibody (1:200, R&D, AF497) and Alexa Fluor 647conjugated donkey anti-goat IgG (1:400, Invitrogen, A21082) were used. For
intracellular CXCL12 staining, cells were ﬁxed and permeabilized using Intracellular Fixation & Permeabilization Buffer (eBioscience), and stained for APCconjugated CXCL12 (1:100, R&D, IC350A). For intracellular SCF staining, cells
were ﬁxed and permeabilized using Intracellular Fixation & Permeabilization
Buffer (eBioscience), and incubated with rabbit anti-SCF polyclonal antibody (1:50,
Bioss, bs-0545R), and subsequently with Alexa Fluor 647-conjugated donkey antigoat IgG (1:400, Invitrogen, A21082).
Cell cycle analyses were performed using DAPI (5 µg/ml). For EdU assays, two
doses of EdU were injected shortly before analysis, at 6 and 3 h prior to sacriﬁce, or
serial doses of EdU were injected for 3 days (3 times a day, total 9 injections). These
pulsed mice were analyzed by histology or ﬂow cytometry using the Click-iT EdU
Alexa Flour 647 Assay kit (Invitrogen, C10634).
Flow cytometry analysis was performed using a four-laser BD LSR Fortessa (Ex.
405/488/561/640 nm) and FACSDiva software. Acquired raw data were further
analyzed on FlowJo software (TreeStar). Representative plots of at least three
independent biological samples are shown in the ﬁgures.
Single-cell RNA-seq analysis of FACS-isolated cells. Cell sorting was performed
using a four-laser BD FACS Aria III (Ex.407/488/561/640 nm) or a six-laser Sony
Synergy SY3200 (Ex.350/405/488/561/594/685 nm) high-speed cell sorter with a
100 µm nozzle. GFP+ cells or tdTomato+ cells were directly sorted into ice-cold
Dulbecco's phosphate-buffered saline (DPBS)/10% fetal bovine serum (FBS), pelleted by centrifugation and resuspended in 10 µl DPBS/1% FBS. Cell numbers were
quantiﬁed by Countless II automated Cell Counter (ThermoFisher) before loading
onto the Chromium Single Cell 3′ v2 or v3 microﬂuidics chip (10× Genomics Inc.,
Pleasanton, CA). cDNA libraries were sequenced by Illumina HiSeq 4000 using two
lanes and 50 cycle paired-end read, generating a total of ~770 million reads, or
NovaSeq 6000. The sequencing data was ﬁrst pre-processed using the 10× Genomics software Cell Ranger. For alignment purposes, we generated and used a
custom genome fasta and index ﬁle by including the sequences of eGFP and
tdTomato-WPRE to the mouse genome (mm10). Further downstream analysis
steps were performed using the Seurat and Monocle R package. We ﬁltered out
cells with less than 500 genes per cell and with more than 20% mitochondrial read
content for v2, or with less than 1000 genes per cell and with more than 15%
mitochondrial read content for v3. The downstream analysis steps include normalization, identiﬁcation of highly variable genes across the single cells, scaling
based on number of UMI, dimensionality reduction (PCA, CCA, and UMAP),
unsupervised clustering, and the discovery of differentially expressed cell-type
speciﬁc markers. Differential gene expression to identify cell-type speciﬁc genes
was performed using the nonparametric Wilcoxon rank sum test.
Colony-forming assay. Nucleated bone marrow cells were plated into tissue culture 6-well plates (BD Falcon) at a density of <105 cells/cm2, and cultured in lowglucose DMEM with GlutaMAX supplement (Gibco 10567022) and 10%
mesenchymal stem cell-qualiﬁed FBS (Gibco 12662029) containing
penicillin–streptomycin (Sigma P0781) for 10–14 days. Cell cultures were maintained at 37 °C in a 5% CO2 incubator. Representative images of at least three
independent biological samples are shown in the ﬁgures.
Subcloning and in vitro trilineage differentiation. Colonies marked by tdTomato
were individually subcloned. A tile-scanned virtual reference of tdTomato+ colonies and cloning cylinders (Bel-Art) were used to isolate an individual colony.
Single cell-derived clones of tdTomato+ cells were cultured in a basal medium
described above at 37 °C with 5% CO2 with exchanges into fresh media every
3–4 days. Cells at Passage 4–7 were used for trilineage differentiation. To induce
chondrocyte differentiation, cells were transferred into a non-tissue culture-coated
V-bottom 96-well plate (Corning 3896). The plate was centrifuged at 150g for
5 min at room temperature to pellet the cells, and the supernatant was carefully
aspirated. StemPro Chondrogenesis medium (ThermoFisher A1007101) was gently
added, and the plate was centrifuged at 150g for 5 min at room temperature to
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pellet the cells. The pellet was cultured in the differentiation medium with
exchanges into fresh media every 3–4 days for up to 3 weeks, each time with
centrifugation at 150g for 5 min at room temperature to repellet the cells. Cell
pellets were ﬁxed with 70% ethanol for 5 min. and stained for Alcian-Blue Staining
Solution (Millipore TMS-010-C) for 30 min. To induce osteoblast differentiation,
cells were plated on a 48-well plate and cultured with αMEM with GlutaMAX
supplement (Gibco 32571036) with 10% FBS containing 1 µM dexamethasone
(Sigma D4902), 10 mM β-glycerophosphate (Sigma G9422) and 50 µg/ml ascorbic
acid (Sigma A5960) with exchanges into fresh media every 3–4 days for up to
3 weeks. Cells were ﬁxed with 4% paraformaldehyde for 5 min and stained for 2%
Alizarin Red S (Sigma A5533) for 30 min. To induce adipocyte differentiation, cells
were plated on a 48-well plate and cultured with αMEM with GlutaMAX supplement with 10% FBS containing 1 µM dexamethasone (Sigma D4902), 0.5 mM
IBMX (3-Isobutyl-1-methylxanthine, Sigma I5879) and 1 µg/ml insulin (Sigma
I6634) with exchanges into fresh media every 3–4 days for up to 2 weeks. Cells
were stained with LipidTOX Green (Invitrogen H34475, 1:200 in basal medium)
for 3 h at 37 °C, or ﬁxed with 4% paraformaldehyde for 5 min and stained for Oil
Red O (Sigma O0625).
Subcutaneous transplantation of cultured cells. NOD scid gamma (NSG)
(JAX005557) mice were used as recipients for cell transplantation. Mice were
anesthetized through a nose cone, in which 1.5–2% isoﬂurane is constantly provided with oxygen through a vaporizer. Fur was removed with clippers and
depilatory cream in a clean area. Matrigel Matrix (Corning) was mixed with
106–107 cells (cultured Cxcl12-creER+ stromal cells, Passage 10 or higher), and
loaded into an insulin syringe (BD Lo-Dose U-100 Insulin Syringes, BD329461).
The cell–matrix mixture was injected subcutaneously into a designated spot in the
back skin or the calvaria.
Three-dimensional micro-computed tomography analysis. Femurs were dissected and scanned by micro-computed tomography (microCT) (eXplore Locus
SP, GE Healthcare Pre-Clinical Imaging, London, ON, Canada). Scans were
reconstructed at 18 µm isotropic voxel size and analyzed using Microview v2.2 (GE
Healthcare, London, Ontario). To analyze the healing of the 0.9 mm drill hole
defect in the diaphyseal femur, images were re-oriented to align the direction of
drilling with the x-axis. A 0.7 mm diameter cylindrical region of interest (ROI) was
centered immediately inside the cortex, and in the cortical gap with a ﬁxed
thickness of 0.2 mm. This ROI typically spanned the cortical thickness from the
endosteal-to-periosteal surface. Regenerated sites were assessed for bone volume
fraction using a threshold of 2300 Hounsﬁeld Units (HU). A common threshold
was calculated across all samples by using the auto-threshold tool of microView for
each specimen. 3D images were reconstructed using CT-Analyzer (Bruker
microCT).
Statistical analysis. Results are presented as mean values ± S.D. Statistical evaluation was conducted using the Mann–Whitney’s U test or one-way ANOVA.
A p value <0.05 was considered signiﬁcant. No statistical method was used to
predetermine sample size. Sample size was determined on the basis of previous
literature and our previous experience to give sufﬁcient standard deviations of the
mean so as not to miss a biologically important difference between groups. The
experiments were not randomized. All of the available mice of the desired genotypes were used for experiments. The investigators were not blinded during
experiments and outcome assessment. One femur from each mouse was arbitrarily
chosen for histological analysis. Genotypes were not particularly highlighted during
quantiﬁcation.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.

Data availability
The datasets generated during and/or analyzed during the current study are available
from the corresponding author on reasonable request. The single-cell RNA-seq data
presented herein have been deposited in the National Center for Biotechnology
Information (NCBI)’s Gene Expression Omnibus (GEO), and are accessible through
GEO Series accession numbers GSE136970, GSE136973, and GSE136979. The source
data underlying all Figures and Supplementary Figures are provided as a Source Data ﬁle.

Code availability
The custom codes utilized for single cell RNA-seq analysis of this study are publicly
available from the following websites: Seurat 3.0 R package (https://satijalab.org/seurat/)
and Monocle 2 R package (http://cole-trapnell-lab.github.io/monocle-release/).
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